Regional Business Director, Philadelphia PA - TTR (Southern NJ, Eastern & Central PA)

Overview

We are looking for experienced Regional Business Directors (RBDs) to support the promotion of AMVUTTRA® (vutrisiran). AMVUTTRA was approved in 2022 by the FDA as the second-ever RNAi for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults.  The successful candidate will also be responsible for preparing the sales organization for the potential launch and commercialization of AMVUTTRA in the second indication of cardiomyopathy of ATTR amyloidosis. Topline results for this study are expected to be available in late June or early July. 

The RBD will be principally responsible for leading and managing a high-performing team of Business Account Executives, focusing on disease awareness and product education among healthcare professionals managing hATTR amyloidosis patients. This is an incredible opportunity to build a team and shape a market in support of patients, caregivers, and the hATTR amyloidosis community.

The RBD will provide coaching to help ensure every BAE meets or exceeds target. He/she will be critical in the assessment and improvement of field and selling processes. RBDs will also need to provide insights to inform commercial strategy, given their proximity to the market, and ultimately meet and exceed performance targets. The RBD will also need to embody Alnylam values: our commitment to people, sense of purposeful urgency, passion for excellence, innovation & discovery, and open culture as well as our unwavering commitment to integrity.

Additionally, an RBD will be responsible for the creation of a customer-oriented climate that focuses on an understanding of patient and customer needs, value-added services, and seamless execution. Through the building of best-in-class teams, talent development, and regular monitoring and coaching, the RBD will foster a culture of accountability.

The position reports to the Executive Sales Lead role.

Key Responsibilities

• Lead and manage a high-performing team of Business Account Executives, focusing on disease awareness, product education among healthcare professionals managing hATTR amyloidosis patients
• Utilize strong sales management, strategic planning skills, financial acumen, and analytical capabilities to align sales execution with overarching product strategies and market needs.
• Analyze market and proactively develop a forward-thinking action plan, rather than solely reacting to past events. Capable of clearly conveying the current market situation and proposed plan of action to leadership, while also ensuring the team is aligned to future objectives and expectations.
• Coach and develop team members to exceed performance targets, emphasizing compliance and effective local business management through strategic business planning and cross-functional alignment.
• Leverage proximity and familiarity of their market to provide insights that help inform the commercial strategy.
• Attract, manage, and retain top sales talent with a demonstrated experience in diverse specialties.
• Hold the team accountable to sustaining a customer-oriented culture that prioritizes understanding and meeting patient needs, delivering seamless execution and value-added services.
• Allocate and manage regional resources effectively that support targeted strategic and operational excellence.
• Align people, processes, structure, information, and communication systems within a complex ecosystem – both within and across functions.
• Inspire and motivate the team by clearly articulating the strategy and vision for the future.

Qualifications

• Bachelor’s degree required: science focus strongly preferred; MBA/PhD is a plus.
•  7+ years in sales, marketing, commercial operations, and/or account management experience in commercial healthcare organizations (i.e., Biotech, Med Device or Specialty Pharmaceuticals).
• 3+ years of experience in leading teams, experience building out field sales teams preferred
• Rare/orphan disease experience preferred.
• Experience training and managing BAEs to effectively promote multiple specialties.
• US product launch experience is helpful.
• In-depth reimbursement knowledge of Buy/Bill and expertise of Part B & D, working with in-house patient support services team required.
• Hospital / Institution knowledge and expertise with the P&T process.
• Deep experience in Neurology and Cardiology is preferred.
• Knowledge and experience with “site-of-care” development.
• Experience in working in various departments, managing multiple teams (sales, marketing, market access, patient services).
• Demonstrated leadership in working in a matrix environment and influencing management decisions.
• Effective planning, prioritization, management, and organizational skills.
• Must be familiar with relevant legal and regulatory environments in biotech/pharmaceutical industry.
• Significant domestic/regional travel is required (approximately 60 – 70%).
• Valid Driver’s license required.
• Demonstrated commitment to ethics and integrity.

#LI-Remote

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.